Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2349 | 3944 | 42.5 | 90% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
392 | 28400 | HEPATOCYTE GROWTH FACTOR//REGUCALCIN//C MET |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
375 | 3497 | HEPATOCYTE GROWTH FACTOR//C MET//HGF |
22394 | 326 | RON RECEPTOR//HEPATOCYTE GROWTH FACTOR LIKE PROTEIN//RON |
31609 | 121 | MACC1//METASTASIS ASSOCIATED IN COLON CANCER 1//MACC 1 |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | HEPATOCYTE GROWTH FACTOR | Author keyword | 505 | 47% | 20% | 789 |
2 | C MET | Author keyword | 457 | 58% | 13% | 532 |
3 | HGF | Author keyword | 161 | 41% | 8% | 308 |
4 | SCATTER FACTOR | Author keyword | 112 | 68% | 2% | 98 |
5 | NK4 | Author keyword | 96 | 88% | 1% | 45 |
6 | MET | Author keyword | 96 | 34% | 6% | 231 |
7 | C MET INHIBITOR | Author keyword | 81 | 96% | 1% | 25 |
8 | HGF SF | Author keyword | 69 | 66% | 2% | 63 |
9 | MACC1 | Author keyword | 62 | 85% | 1% | 33 |
10 | HEPATOCYTE GROWTH FACTOR HGF | Author keyword | 50 | 48% | 2% | 75 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HEPATOCYTE GROWTH FACTOR | 505 | 47% | 20% | 789 | Search HEPATOCYTE+GROWTH+FACTOR | Search HEPATOCYTE+GROWTH+FACTOR |
2 | C MET | 457 | 58% | 13% | 532 | Search C+MET | Search C+MET |
3 | HGF | 161 | 41% | 8% | 308 | Search HGF | Search HGF |
4 | SCATTER FACTOR | 112 | 68% | 2% | 98 | Search SCATTER+FACTOR | Search SCATTER+FACTOR |
5 | NK4 | 96 | 88% | 1% | 45 | Search NK4 | Search NK4 |
6 | MET | 96 | 34% | 6% | 231 | Search MET | Search MET |
7 | C MET INHIBITOR | 81 | 96% | 1% | 25 | Search C+MET+INHIBITOR | Search C+MET+INHIBITOR |
8 | HGF SF | 69 | 66% | 2% | 63 | Search HGF+SF | Search HGF+SF |
9 | MACC1 | 62 | 85% | 1% | 33 | Search MACC1 | Search MACC1 |
10 | HEPATOCYTE GROWTH FACTOR HGF | 50 | 48% | 2% | 75 | Search HEPATOCYTE+GROWTH+FACTOR+HGF | Search HEPATOCYTE+GROWTH+FACTOR+HGF |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | FACTOR SCATTER FACTOR | 872 | 62% | 23% | 904 |
2 | C MET | 660 | 47% | 26% | 1026 |
3 | SCATTER FACTOR | 559 | 55% | 18% | 694 |
4 | MACROPHAGE STIMULATING PROTEIN | 292 | 77% | 5% | 197 |
5 | HGF RECEPTOR | 271 | 83% | 4% | 151 |
6 | HEPATOCYTE GROWTH FACTOR | 265 | 22% | 27% | 1050 |
7 | HEPATOPOIETIN A | 222 | 80% | 3% | 136 |
8 | MET HGF RECEPTOR | 147 | 71% | 3% | 119 |
9 | FACTOR HGF | 146 | 69% | 3% | 123 |
10 | HGF | 125 | 56% | 4% | 151 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Targeting MET in cancer: rationale and progress | 2012 | 354 | 174 | 66% |
Met, metastasis, motility and more | 2003 | 1326 | 104 | 68% |
MET signalling: principles and functions in development, organ regeneration and cancer | 2010 | 306 | 162 | 56% |
Drug development of MET inhibitors: targeting oncogene addiction and expedience | 2008 | 352 | 124 | 76% |
The emerging role of MET/HGF inhibitors in oncology | 2013 | 45 | 94 | 87% |
c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention | 2005 | 280 | 206 | 87% |
Scatter-factor and semaphorin receptors: Cell signalling for invasive growth | 2002 | 430 | 147 | 66% |
MET: a promising anticancer therapeutic target | 2012 | 85 | 133 | 77% |
Hepatocyte growth factor twenty years on: Much more than a growth factor | 2011 | 102 | 72 | 83% |
The MET receptor tyrosine kinase in invasion and metastasis | 2007 | 144 | 115 | 81% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MOL REGENERAT MED | 47 | 40% | 2.3% | 91 |
2 | COURSE ADV MED | 44 | 58% | 1.3% | 50 |
3 | KRINGLE PHARMA JOINT REGENERAT DRUG DISCO | 34 | 70% | 0.7% | 28 |
4 | TUMOR DYNAM REGULAT | 18 | 45% | 0.8% | 30 |
5 | BIOCHEMBIOMED | 17 | 100% | 0.2% | 8 |
6 | ONCOL BIOCHEM | 15 | 45% | 0.6% | 25 |
7 | IRCC | 8 | 28% | 0.7% | 26 |
8 | ONCOLBIOMED | 6 | 71% | 0.1% | 5 |
9 | CANC TREATMENT IRCC | 6 | 24% | 0.5% | 21 |
10 | PK ANALYT CHEM | 6 | 100% | 0.1% | 4 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000021352 | BIOARTIFICIAL LIVER//LIVER REGENERATION//HEPATOCYTE TRANSPLANTATION |
2 | 0.0000009990 | NON SMALL CELL LUNG CANCER//XRCC1//GEFITINIB |
3 | 0.0000008260 | FIBROBLAST GROWTH FACTOR//KERATINOCYTE GROWTH FACTOR//SPROUTY |
4 | 0.0000008126 | FOCAL ADHESION KINASE//INTEGRIN LINKED KINASE//FAK |
5 | 0.0000008104 | EPITHELIAL MESENCHYMAL TRANSITION//EMT//SNAIL |
6 | 0.0000008079 | NOONAN SYNDROME//COSTELLO SYNDROME//THROMBOSPONDIN 1 |
7 | 0.0000007561 | HER 2//TRASTUZUMAB//LAPATINIB |
8 | 0.0000007355 | TETRASPANIN//CD9//CD151 |
9 | 0.0000006861 | ENDOTHELIAL PROGENITOR CELLS//ENDOTHELIAL PROGENITOR CELL//ARTERIOGENESIS |
10 | 0.0000006727 | IQGAP1//LRIG1//MIG 6 |